Updated Jul 16, 2026
Shields David Stanley has filed 1 SEC Form 4 filing across 1 company in the last 90 days.

Shields David Stanley is listed as a director for CapsoVision, Inc. in the most recent SEC filing dated July 2, 2026. CapsoVision, Inc. is a medical device company known for capsule endoscopy technology. Public information available from SEC filings provides only the director role for this individual; there is limited publicly accessible detail on education, career history, or prior board service. Be aware of possible name variations (e.g., David S. Shields, D. Stanley Shields) when cross-referencing records. As of the filing date, there is no public indication that Shields David Stanley is deceased.
| Role | Director |
|---|---|
| Notability | 40/100 |
Shields David Stanley is listed as a director for CapsoVision, Inc. in the most recent SEC filing dated July 2, 2026. CapsoVision, Inc. is a medical device company known for capsule endoscopy technology. Public information available from SEC filings provides only the director role for this individual; there is limited publicly accessible detail on education, career history, or …
1 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Shields David Stanley profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.